Pain
FDA/CDC
FDA OKs new high-dose naloxone product for opioid overdose
“The higher intramuscular doses of naloxone in ZIMHI should result in more rapid and higher levels of naloxone in the systemic circulation.”
From the Journals
New antimigraine drugs linked with less risk for adverse events
The safety and efficacy of new antimigraine treatments were compared with current standard therapy, in a new systematic review.
From the Journals
Retraining the brain may eliminate chronic back pain
The effects of pain-reprocessing therapy on pain were mediated by lessening the belief that pain indicates tissue damage, the researchers said.
Families in Psychiatry
Old wives’ tales, traditional medicine, and science
Every village must contend with finding the balance between traditional medical knowledge and the discoveries of science, said Dr. Alison M. Heru...
Feature
Opioid prescribing mapped: Alabama highest, New York lowest
The Medicare Part D opioid prescribing rate dropped in all 50 states from 2014 to 2019, but disparities remain.
FDA/CDC
FDA okays new oral CGRP antagonist for migraine prevention
With this approval, neurologists will be able to choose from four monoclonal antibodies and two gepants for the preventive treatment of migraine...
Feature
‘Alarming’ increase in fake pills laced with fentanyl, methamphetamine, DEA warns
More than 9.5 million fake pills have been seized so far this year – more than the last 2 years combined.
Guidelines
Guideline gives weak support to trying oral medical cannabis for chronic pain
Does oral medical cannabis work in chronic pain? Here’s what the evidence says.
Feature
As opioid deaths climb, human trials begin for vaccine
The first vaccine to enter a trial targets oxycodone.
From the Journals
Opioid overdoses tied to lasting cognitive impairment
One study in the review found that about 39% of people seeking buprenorphine treatment suffered from neurocognitive impairment.
Conference Coverage
Growing proportion of cardiac arrests in U.S. considered opioid related
Due to a steep rise, opioid-associated cardiac arrests have become a major public health issue.